L-proline and citric acid co-crystals of (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

PK201200292A0Active Publication Date: 2012-06-06JANSSEN PHARMA NV
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
JANSSEN PHARMA NV
Filing Date
2012-05-09
Publication Date
2012-06-06
Patent Text Reader

Abstract

The present invention is directed to L-proline and citric acid co-crystals of (2S,3R,4R,5S,6R)-2-(3((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4methylphenyl)-6-(hydroxymethyl)tetrahydro-2Hpyran-3,4,5-triol, pharmaceutical compositions containing said co-crystals and their use in the treatment glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
Need to check novelty before this filing date? Find Prior Art